SCHEMBL23115488

SCHEMBL23115488

COc1ccc(-c2[nH]c3ccc(-c4nn[c]o4)cc3c2C(C)C)cc1OC

nearest known ligand 0.70

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
TLR8 Q9NR97 20/20 0.70
TLR7 Q9NYK1 20/20 0.70
TLR9 Q9NR96 12/20 0.64

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23115547 0.83 TLR8 (0.65) TLR8TLR7TLR9
SCHEMBL30602226 0.82 TLR8 (1.00) TLR8TLR7TLR9
SCHEMBL22575776 0.82 TLR8 (1.00) TLR8TLR7TLR9
SCHEMBL28438843 0.82 TLR8 (0.67) TLR8TLR7TLR9
SCHEMBL23115564 0.81 TLR7 (0.67) TLR8TLR7TLR9
SCHEMBL7303064 0.79 ALDH1A1 (0.55)
SCHEMBL26580793 0.79 TLR8 (0.75) TLR8TLR7TLR9
SCHEMBL22575864 0.78 TLR8 (1.00) TLR8TLR7TLR9
SCHEMBL22575867 0.78 TLR8 (1.00) TLR8TLR7TLR9
SCHEMBL29093396 0.78 TLR8 (0.76) TLR8TLR7TLR9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-111491918-B Aryl and heteroaryl substituted indole compounds 百时美施贵宝公司 2023-10-24 CN claimed
US-20210087174-A1 ARYL AND HETEROARYL SUBSTITUTED INDOLE COMPOUNDS BRISTOL MYERS SQUIBB CO (US) 2021-03-25 US claimed
CN-111491918-A Aryl and heteroaryl substituted indole compounds 百时美施贵宝公司 2020-08-04 CN claimed
CN-111491918-B Aryl and heteroaryl substituted indole compounds 百时美施贵宝公司 2023-10-24 CN disclosed
CN-111491918-A Aryl and heteroaryl substituted indole compounds 百时美施贵宝公司 2020-08-04 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210087174-A1 ARYL AND HETEROARYL SUBSTITUTED INDOLE COMPOUNDS TLR7, TLR1, TLR9 TLR8 4/4885TLR7 1/4885TLR9 3/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.